<- Go Home

Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.

Market Cap

CHF 240.6B

Volume

1.2M

Cash and Equivalents

CHF 7.6B

EBITDA

CHF 23.4B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

CHF 47.5B

Profit Margin

74.79%

52 Week High

CHF 313.80

52 Week Low

CHF 231.90

Dividend

3.46%

Price / Book Value

7.79

Price / Earnings

23.88

Price / Tangible Book Value

51.40

Enterprise Value

CHF 267.6B

Enterprise Value / EBITDA

11.29

Operating Income

CHF 20.3B

Return on Equity

31.32%

Return on Assets

13.30

Cash and Short Term Investments

CHF 12.0B

Debt

CHF 34.6B

Equity

CHF 33.0B

Revenue

CHF 63.5B

Unlevered FCF

CHF 12.5B

Sector

Pharmaceuticals

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches